Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 2010 Mar 8;160(4):836–843. doi: 10.1111/j.1476-5381.2010.00657.x

Impairment of endothelial SKCa channels and of downstream hyperpolarizing pathways in mesenteric arteries from spontaneously hypertensive rats

AH Weston 1, EL Porter 1, E Harno 1, G Edwards 1
PMCID: PMC2935991  PMID: 20233221

Abstract

Background and purpose:

Previous studies have shown that endothelium-dependent hyperpolarization of myocytes is reduced in resistance arteries from spontaneously hypertensive rats (SHRs). The aim of the present study was to determine whether this reflects down-regulation of endothelial K+ channels or their associated pathways.

Experimental approach:

Changes in vascular K+ channel responses and expression were determined by a combination of membrane potential recordings and Western blotting.

Key results:

Endothelium-dependent myocyte hyperpolarizations induced by acetylcholine, 6,7-dichloro-1H-indole-2,3-dione 3-oxime (NS309) (opens small- and intermediate-conductance calcium-sensitive K+ channels, SKCa and IKCa, respectively) or cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine (SKCa opener) were reduced in mesenteric arteries from SHRs. After blocking SKCa channels with apamin, hyperpolarizations to acetylcholine and NS309 in SHR arteries were similar to those of controls. Hyperpolarization to 5 mM KCl was reduced in SHR arteries due to loss of the Ba2+-sensitive, inward-rectifier channel (KIR) component; the contribution of ouabain-sensitive, Na+/K+-ATPases was unaffected. Protein expression of both SKCa and KIR channels was reduced in SHR arteries; the caveolin-1 monomer/dimer ratio was increased.

Conclusions and implications:

In SHRs, the distinct pathway that generates endothelium-dependent hyperpolarization in vascular myocyte by activation of IKCa channels and Na+/K+-ATPases remains intact. The second pathway, initiated by endothelial SKCa channel activation and amplified by KIR opening on both endothelial cells and myocytes is compromised in SHRs due to down-regulation of both SKCa and KIR and to changes in caveolin-1 oligomers. These impairments in the SKCa–KIR pathway shed new light on vascular control mechanisms and on the underlying vascular changes in hypertension.

This article is commented on by Garland, pp. 833–835 of this issue. To view this commentary visit http://dx.doi.org/10.1111/j.1476-5381.2010.00692.x

Keywords: hypertension, EDHF, acetylcholine, apamin, TRAM-34, CyPPA, NS309, KCa3.1, KCa2.3, caveolin-1

Introduction

The endothelium plays an important role in the control of vascular tone and thus endothelial dysfunction can be a contributory factor in hypertension. Endothelium-derived nitric oxide and prostacyclin are major contributors to vasorelaxation but, in addition, myocyte hyperpolarization initiated by the opening of endothelial cell K+ channels also induces vasodilatation (Félétou and Vanhoutte, 2007). This hyperpolarization was initially thought to be due to the release of an endothelium-derived hyperpolarizing factor (EDHF) and, for want of a better name, the term ‘EDHF’ is still employed to describe this phenomenon. Nevertheless, it is now universally accepted that, in most arteries, the myocyte hyperpolarization results indirectly from the opening of endothelial cell small- and intermediate-conductance, calcium-sensitive K+ channels (SKCa and IKCa, respectively; ion channel nomenclature follows Alexander et al., 2009). In some small arteries (such as the rat hepatic artery), the K+ that leaves the endothelium via these channels induces activation of myocyte Na+/K+-ATPase (types 2 or 3) and partially relieves the rectifying block of inward-rectifier K+ channels (KIR), both of which actions result in smooth muscle hyperpolarization (Edwards et al., 1998). In other vessels (such as guinea-pig internal carotid arteries), the hyperpolarization of the endothelium (due to the opening of the SKCa and IKCa channels) is transferred electrotonically to the myocytes via gap junctions (Edwards et al., 1999a). In the rat mesenteric artery, which is commonly used to study the EDHF response, both of these pathways appear to play important roles (Edwards et al., 1999a). In addition, it is now recognized that the sub-cellular distribution of the various components of the EDHF pathway is likely to be of relevance. Thus, the localization of SKCa channels to caveolae may be an important requisite for maximal activity (Absi et al., 2007) and the clustering of IKCa channels together with Na+/K+-ATPases in endothelial cell projections may facilitate myo-endothelial cell coupling (Sandow et al., 2006; Dora et al., 2008; Harno et al., 2008).

Several groups have reported that the EDHF response is impaired in various rat models of hypertension (see Fujii et al., 1992; Sunano et al., 1999; Alvarez de Sotomayor et al., 2007;Hilgers and Webb, 2007; Dal-ros et al., 2009) although the underlying cause has not been fully established. In view of our current understanding of the EDHF response, and the differential distribution of the two endothelial K+ channels (Sandow et al., 2006; Absi et al., 2007; Dora et al., 2008), the aim of the present study was to elucidate further the mechanisms underlying the reduced endothelium-dependent hyperpolarization in hypertensive rats. The study found no modification to endothelial cell IKCa channel signalling pathways. However, there was strong electrophysiological evidence of reduced SKCa and KIR channel activity in the mesenteric arteries of spontaneously hypertensive rats (SHR). This was consistent with observed reductions in the corresponding α-subunit proteins, KCa2.3 and KIR2.1. These changes, together with alterations in oligomeric forms of caveolin-1, show that an important endothelium-dependent vasodilator pathway is compromised in the mesenteric vessels of SHR. These are likely to lead to an increase in vascular tone in vivo and be underlying features responsible for the elevated blood pressure that is characteristic of the SHR strain.

Methods

Animals

All animal care and experimental procedures complied with the UK Animals (Scientific Procedures) Act, 1986. All animals were housed under a 12 h light–dark cycle with food and water available ad libitum. Systolic blood pressure was determined using tail-cuff plethysmography. Experiments were performed on second- and third-order mesenteric artery branches (approximately 150–250 mm diameter) dissected from 12- to 16-week-old male, SHR (mean body weight 298 ± 9 g, n= 20) and from strain- and age-matched normotensive Wistar-Kyoto (WKY) rats (mean body weight 295 ± 10 g, n= 19) killed by stunning and cervical dislocation.

Electrophysiology

Small segments of artery (second or third order; length 2–3 mm) were pinned to the Sylgard base of a thermostatically controlled bath and superfused (3 mL·min−1) with a Krebs solution containing 10 µM indomethacin and 300 µM NG-nitro-L-arginine (L-NA) and which was bubbled with 95% O2/5% CO2 (pH 7.5; 37°C). The composition of the Krebs solution was (mM): NaCl, 118; KCl, 3.4; CaCl2, 1.0; KH2PO4, 1.2; MgSO4, 1.2; NaHCO3, 25; glucose, 11. For membrane potential recordings, myocytes were impaled via the adventitial surface using microelectrodes filled with 3 M KCl (resistance 40–80 MΩ) as described previously (Edwards et al., 1999b). Acetylcholine (ACh), cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine (CyPPA) and levcromakalim were each added as bolus injections directly into the bath in quantities calculated to obtain (transiently) the final concentrations indicated. Apamin, barium, ouabain and 1-[(2-chlorophenyl)-diphenyl-methyl]-1H-pyrazole (TRAM-34) were each added to the reservoir of Krebs solution superfusing the bath.

Western blotting

Western blotting was performed (as described previously; Gardener et al., 2004) to determine any changes in the protein expression of the SKCa, IKCa and KIRα-subunits (KCa2.3, KCa3.1 and KIR2.1 respectively) and of caveolin-1. Briefly, endothelium-intact segments of rat mesenteric artery were homogenized in freshly prepared extraction buffer comprising 20 mM Tris, 250 mM sucrose, 5 mM EDTA, 10 mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulphonylfluoride, 0.1% Triton X-100 and protease inhibitor cocktail (one vial per 100 mL of extraction buffer). Protein concentrations were determined using a Bradford reagent (Protein Assay, Bio-Rad, Hertfordshire, UK) and, for each lane, equal protein loading and transfer were visually assessed after staining for 5 min with 0.1% Ponceau S solution (Sigma-Aldrich, Dorset, UK). Consistency of protein loading was further confirmed by Western blot using β-actin as a loading control. Samples were mixed with Laemmli buffer (containing the detergent SDS; Laemmli, 1970), heated to 60°C (KCa2.3) or to 95°C for 5 min then separated on 8% (KCa2.3), 10% (KIR2.1) or 12% (caveolin-1) polyacrylamide gels (as indicated) and transferred to nitrocellulose membranes.

The membranes were blocked with 2% bovine serum albumin (1 h at room temperature or overnight at 4°C) then incubated for 1 h at room temperature/overnight at 4°C with 1:500 rabbit anti-KCa2.3 antibody (anti-KCNN3, Abcam, Cambridge, UK), 1:200 rabbit anti-KIR2.1 (Alomone, Jerusalem, Israel) or 1:5000 mouse anti-caveolin-1 antibody (BD Transduction Laboratories, Oxford, UK). Detection was achieved using horseradish peroxidase-conjugated goat anti-rabbit (1:5000, Promega, Madison, WI, USA) or goat anti-mouse secondary antibody (1:20 000; Jackson ImmunoResearch, Cambridge, UK) and ECL+ reagents (GE Healthcare, Bucks., UK). Following stripping with Western-Re-Probe Reagent (1:5, Calbiochem, San Diego, CA, USA), membranes were re-probed by incubating for 1 h at room temperature/overnight at 4°C with 1:2000 anti-β-actin (mouse monoclonal; AC15; Abcam, Cambridge, UK) and immunoreactivity detected as above.

Statistics

Results were analysed by two-way anova (with Bonferroni's post hoc test) or Student's t-test as appropriate and are expressed as means ± SEM. A P-value of 0.05 was considered significant.

Materials

CyPPA was generously provided by Dr H Draheim, Boehringer Ingelheim, Biberach, Germany. NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime) was donated by Dr P Christophersen (Neurosearch A/S, Denmark). TRAM-34 was purchased from Toronto Research Chemicals, Toronto, Canada. Unless otherwise mentioned, all other drugs and chemicals were obtained from Sigma-Aldrich, Poole, UK.

Indomethacin was dissolved in absolute ethanol and barium in deionized water (10 mM stocks). CyPPA was prepared as a 100 mM stock and ACh, TRAM-34, NS309 and levcromakalim were prepared as 10 mM stock solutions in ethanol and subsequently diluted in Krebs solution. L-NA and ouabain were dissolved directly in Krebs solution.

Results

Systolic blood pressure was elevated in SHRs in comparison with WKYs (systolic, SHR: 235 ± 5 mmHg, n= 20; WKY: 174 ± 4 mmHg, n= 16; Student's t-test, P < 0.0001; diastolic, SHR: 157 ± 6 mmHg, n= 20, WKY: 112 ± 7 mmHg, n= 16, P < 0.0001) although the heart rate in the SHRs (414 ± 8 bpm, n= 20) was similar to that of WKYs (411 ± 13 bpm, n= 16) and the mean body weights did not differ (SHR, 293 ± 12 g, n= 17; WKY, 286 ± 11 g, n= 15).

Effects of ACh and NS309: evidence that SKCa channels are reduced in SHR vessels

In artery segments with an intact endothelium, the resting membrane potential of SHR mesenteric artery myocytes (−49.3 ± 0.4 mV, n= 12) was depolarized compared with that of the WKY controls (−53.6 ± 0.4 mV, n= 12; Student's t-test, P < 0.0001). ACh produced concentration-dependent myocyte hyperpolarizations that were significantly smaller in arteries from SHR animals than those in WKY arteries (P= 0.001, n= 4; two-way anova; Figure 1). In contrast, NS309 (100 nM, an activator of both SKCa and IKCa channels) hyperpolarized SHR myocytes to a similar extent (two-way anova with Bonferroni post-test, P > 0.05) in segments of artery from both SHR (by 13.5 ± 1.6 mV, n= 4) and WKY (by 16.0 ± 1.2 mV, n= 4) rats. To determine whether these results somehow reflected a change in the population of SKCa or IKCa channels in SHR myocytes, additional experiments were first conducted in the presence of apamin to block SKCa channels and thus to ensure that any changes subsequently mediated by either ACh or NS309 resulted from the opening of IKCa alone.

Figure 1.

Figure 1

Comparison of hyperpolarizations induced by acetylcholine (ACh), 6,7-dichloro-1H-indole-2,3-dione 3-oxime (NS309) and levcromakalim (LK) in rat mesenteric artery segments from spontaneously hypertensive rat (SHR) and Wistar-Kyoto rat (WKY) controls. (A) ACh induced a concentration-dependent myocyte hyperpolarization that was significantly greater in segments from WKY than in those from SHR (P= 0.001; two-way anova). (B) In the presence of 0.1 µM apamin, the responses to ACh were reduced in artery segments from WKY but not from SHR. (C) In the additional presence of 10 µM 1-[(2-chlorophenyl)-diphenyl-methyl]-1H-pyrazole (TRAM-34), responses to ACh were almost abolished (the small, residual hyperpolarization is assumed to be due to activation of myocyte BKCa channels by nitric oxide). In the presence of TRAM-34 + apamin, there was no difference in the peak hyperpolarization induced by LK, suggesting that the myocyte EK was similar in WKY and SHR vessels. Each bar represents mean membrane potential (m.p.) before, and peak response to, ACh or LK (±SEM, n= 4); asterisks indicate statistically significant differences between hyperpolarizations in the indicated groups (Bonferroni post-test; **P < 0.01; NS, not significant).

Apamin itself (100 nM; an SKCa blocker) had minimal effects on myocyte membrane potential in both SHR and WKY vessels. In SHR arteries, apamin also had no effect on responses to ACh or NS309 (two-way anova) whereas the effects of each agent in WKY rats were reduced following SKCa blockade (Figure 1A,B; P < 0.004). One explanation for these findings was that the population of SKCa channels in hypertensive vessels was somehow reduced whereas the IKCa-mediated component of hyperpolarizations to ACh or NS309 (and revealed in the presence of apamin) was apparently unchanged (Figure 1A,B: Bonferroni post-test, P > 0.05).

To confirm that the residual hyperpolarizations observed in the presence of apamin did result from the opening of IKCa channels, TRAM-34 (10 µM; a blocker of IKCa) was subsequently added to the Krebs solution that already contained apamin. Under these conditions, the effects of NS309 were indeed abolished.

To provide some indication of the integrity of vessels at the end of these long impalements, arteries were finally challenged with 10 µM levcromakalim, an opener of myocyte ATP-sensitive K+ channels. Levcromakalim hyperpolarized the membrane to a similar potential in the arteries from WKY and SHR rats (WKY, −77.7 ± 0.6 mV; SHR, −77.4 ± 1.2 mV, each n= 4; Figure 1C), an indication that these vessels were still in good condition.

Experiments with CyPPA: confirmation that SKCa channels are compromised in SHR vessels

The possible reduction in the SKCa component of the hyperpolarization to ACh could have been due to loss of muscarinic M3 receptors, to modified receptor–channel coupling or to a loss of SKCa channels in SHR artery segments. In order to investigate this further, hyperpolarizations to CyPPA (a directly acting, selective opener of SKCa channels; Hougaard et al., 2007) were elicited. This cyclohexylamine produced myocyte hyperpolarizations in endothelium-intact segments from both SHR and WKY rats and these changes were significantly smaller in arteries from hypertensive animals (CyPPA, 30 µM: SHR 8.8 ± 0.9 mV; WKY 19.4 ± 0.4 mV; both n= 4, P < 0.0001, two-way anova). In the presence of the SKCa inhibitor, apamin (100 nM), the effects of CyPPA were always totally abolished, confirming that CyPPA-induced hyperpolarizations were indeed due solely to the opening of SKCa channels (Figure 2).

Figure 2.

Figure 2

Comparison of hyperpolarizations induced by CyPPA (cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine) and levcromakalim (LK) in rat mesenteric artery segments from spontaneously hypertensive rat (SHR) and Wistar-Kyoto rat (WKY) controls. (A) Typical trace showing concentration-dependent smooth muscle hyperpolarization induced by CyPPA (a selective opener of SKCa, native small-conductance, calcium-sensitive K+ channel) in a segment of artery from a WKY rat. (B) Mean results showing significantly greater hyperpolarization to CyPPA in segments from WKY than from SHR (P= 0.001; two-way anova). In contrast, there was no difference in the membrane potential (m.p.) to which LK hyperpolarized the myocytes, suggesting that the myocyte equilibrium potential for K+ was similar in WKY and SHR vessels. Each bar represents mean membrane potential (m.p.) before, and peak response to, acetylcholine or LK (±SEM, n= 4); asterisks indicate statistically significant differences between hyperpolarizations in the indicated groups (Bonferroni post-test; *P < 0.05; ***P < 0.001).

Collectively, these findings with ACh, NS309 and with CyPPA strongly indicate that either the number of functional SKCa channels and/or the pathways downstream of SKCa activation are compromised in SHR vessels.

Modification of SKCa-activated downstream pathways in SHR vessels

The activation of endothelial IKCa and SKCa channels generates an increase in the [K+] in the myo-endothelial space that we have called the ‘K+ cloud’ (Edwards et al., 1998; Edwards and Weston, 2004). Recent evidence suggests that the apamin-sensitive component of the EDHF response (associated with a localized K+ cloud that originates from K+ efflux through SKCa opening) is coupled to the subsequent activation of Ba2+-sensitive, inwardly rectifying K+ channels (KIR). The K+ cloud, which originates from TRAM-34-sensitive, IKCa opening, predominantly then signals to the myocytes via activation of an isoform of Na+/K+-ATPase that is sensitive to low concentrations of ouabain (Dora et al., 2008; Harno et al., 2008).

Thus, to determine whether pathways downstream of SKCa activation were compromised in SHR vessels, hyperpolarizations generated following 5 mM elevation of extracellular [K+] were used as a simple paradigm of the localized K+-coupling process.

In the absence of the endothelium, the hyperpolarizations induced by 5 mM K+ were smaller in SHR arteries (6.7 ± 0.3 mV, n= 4) than in WKY vessels (9.8 ± 0.6 mV, n= 4; Student's t-test, P= 0.003; Figure 3A). These presumably resulted from the activation of both Na+/K+-ATPases and KIR; to reveal the contribution of KIR, 500 nM ouabain was added to the Krebs solution to inhibit myocyte Na+/K+-ATPases. Under these conditions, the hyperpolarizations induced by 5 mM K+ were smaller in SHR arteries (1.2 ± 0.3 mV, n= 4) than in WKY vessels (5.9 ± 0.8 mV, n= 4; Student's t-test, P= 0.002; Figure 3A) and were abolished by 30 µM Ba2+, indicating that they were indeed generated by KIR activation.

Figure 3.

Figure 3

Effects of ouabain and barium on rat mesenteric artery myocyte hyperpolarizations to extracellular K+. (A) In the absence of a functional endothelium, the resting membrane potential of the spontaneously hypertensive rat (SHR) artery myocytes was depolarized relative to that of the Wistar-Kyoto rat (WKY) myocytes (P= 0.005) and the hyperpolarizing effect of elevation of extracellular K+ (by 5 mM) was reduced. The magnitude of the depolarization to ouabain was similar in SHR myocytes and WKY myocytes (each n= 4; P= 0.47). Elevation of extracellular K+ by 5 mM produced a hyperpolarization that was partially inhibited by ouabain in segments of artery from SHR but not in those from WKY controls. (B) Hyperpolarizations to K+ were increased by the presence of an intact endothelium but, under these conditions, significant inhibition by ouabain was only produced in the SHR artery segments. In the presence of both barium and ouabain, all responses to K+ elevation were abolished. Each bar represents mean membrane potential (m.p.) before, and peak response to, acetylcholine or levcromakalim (LK) (±SEM, n= 4); asterisks indicate that differences between hyperpolarizations in the indicated groups were statistically significant (Student's t-test; **P < 0.005; ***P < 0.001; NS, not significant).

In the presence of the endothelium (Figure 3B), hyperpolarizations to exogenous (5 mM) K+ were slightly (but significantly, P < 0.05, Student's t-test) greater (WKY, 13.2 ± 1.2 mV, n= 4; SHR, 10.1 ± 0.8 mV, n= 4) than in its absence (WKY, 9.8 ± 0.6 mV, n= 4; SHR, 6.7 ± 0.3 mV, n= 4). Under these conditions, addition of ouabain (500 nM) almost abolished the hyperpolarizing effect of K+ but had no significant effect on the hyperpolarization to 5 mM K+ in WKY arteries. In all endothelium-intact artery segments, addition of barium (30 µM) to the ouabain-Krebs abolished the residual response to K+ (Figure 3B).

Taken together, these effects of increasing the bath K+ concentration by 5 mM suggest that there is a reduction in functional KIR channels in SHR arteries.

Western blotting

A polyclonal antibody was used for Western blot analysis of the KCa2.3 α-subunit expression in lysates of SHR and WKY mesenteric arteries. When SHR blot densities were adjusted according to their corresponding β-actin level and normalized relative to those from WKY samples, they showed a marked reduction in KCa2.3 immunoreactivity in SHR mesenteric arteries in comparison with those from WKY rats (Figure 4Ai,Bi). Using identical procedures, there was also a significant reduction in KIR2.1 α-subunit protein expression in SHR arteries compared with vessels from the WKY controls (Figure 4Aii,Bii) whereas there was a marked increase in caveolin-1 (monomer) protein expression in vessels derived from the hypertensive rats (Figure 4Aiii,Biii). However, the concentration of the dimeric form was reduced (Figure 4Aiii,Biii), so the total relative concentration of caveolin-1 protein was essentially unchanged (P > 0.05; Student's t-test).

Figure 4.

Figure 4

Changes in protein expression in mesenteric arteries from spontaneously hypertensive rat (SHR). Upper panel: typical Western blots for (i) KCa2.3 (ii) KIR2.1 and (iii) caveolin-1 monomer and dimer, with size (kDa) of immunoreactive blot indicated. The three lanes on the left are from samples obtained from three different Wistar-Kyoto (WKY) rats and on the right are from three different SHRs. Lower panel: blots were stripped and re-probed for β-actin. (B) Semi-quantitative analysis of mean protein expression in SHR arteries relative to that of controls. Mean blot density (+SEM) for lysates from seven mesenteric beds showed significant reductions in (i) SKCa2.3 and (ii) KIR2.1 protein and (iii) a large increase in caveolin-1 monomer and decrease in caveolin-1 dimer protein expression in SHR artery preparations relative to those from WKY (samples were adjusted for loading errors, using the β-actin blot density to standardize, prior to normalization relative to WKY values). Asterisks indicate the statistical significance of differences in relative protein concentrations in the SHR arteries compared with the corresponding WKY controls (Student's t-test; *P < 0.05; ***P < 0.0001).

Discussion

Reduced hyperpolarization in SHR arteries reflects a modified SKCa channel pathway

The results from the present study clearly indicate that the ACh-induced myocyte hyperpolarization (the so-called EDHF response which in normal vessels follows from the activation of both endothelial SKCa and IKCa channels) is reduced in SHR arteries, an effect due largely to selective modification of pathways associated with activation of the SKCa component.

Thus, total ACh-mediated hyperpolarizations (activated by the interaction of ACh with the muscarinic M3 receptor; Hammarström et al., 1995; Wu et al., 1997) in SHR vessels were halved in magnitude (compared with WKY controls), whereas the ACh-activated IKCa component (studied in the presence of apamin) was the same in both WKY and SHR arteries. This suggested that there had been a near abolition of the SKCa component in the SHR vessels. The unchanged IKCa component indicated that the endothelial M3 receptor itself was unlikely to have been altered in the SHR vessels.

To test this directly, we made Western blot measurements of the expression of M3 receptor protein using the Alomone AMR-006 anti-M3 antibody. The results were, however, unclear, yielding multiple protein bands (data not presented) from which no firm conclusions could be drawn. Equivocal results were also obtained by measuring myocyte hyperpolarizations produced by NS309, the M3 receptor-independent opener of IKCa and SKCa channels. These electrical changes were not significantly reduced in SHR arteries, perhaps reflecting the known selectivity of NS309 for IKCa (Strøbaek et al., 2004). However, hyperpolarizations to CyPPA (a selective opener of SKCa channels; Hougaard et al., 2007) were substantially reduced in SHR vessels. Furthermore, Western blot analysis showed that expression of the SKCaα-subunit protein (KCa2.3; Burnham et al., 2002; Alexander et al., 2009) was also markedly diminished in SHR vessels.

Collectively, these findings strongly support the conclusion that the SKCa pathway (and specifically the channel protein itself) is down-regulated in the hypertensive animals. A similar reduction in KCa2.3 mRNA and protein in mesenteric arteries from angiotensin II-induced hypertensive rats (Hilgers and Webb, 2007), together with the induction of hypertension in KCa2.3 gene-depleted mice (Taylor et al., 2003), suggests that loss of SKCa may indeed be a general feature of a long-term increase in blood pressure.

Changes downstream of endothelial SKCa channel activation: additional down-regulation of KIR in SHR vessels

Recent studies, using a combination of electrophysiological, ultrastructural and pharmacological techniques, have shown that activation of endothelial IKCa channels triggers myocyte hyperpolarization by mechanisms that are distinct from those that follow the opening of SKCa channels. Thus, endothelial cell IKCa-induced myocyte hyperpolarizations involve subsequent activation of types 2 and 3 Na+/K+-ATPases (Dora et al., 2008; Harno et al., 2008). In contrast, the dilator pathway triggered by endothelial cell SKCa channel opening is associated with the subsequent activation of KIR (Dora et al., 2008; Harno et al., 2008).

To determine whether these downstream pumps and channels (i.e. the Na+/K+-ATPases and /or KIR channels) were, in addition to SKCa channels, functionally altered in SHR vessels, the simple technique of raising extracellular [K+] (Edwards et al., 1998; Weston et al., 2002) was used to induce myocyte hyperpolarizations in the presence or absence of barium (to block KIR) and ouabain (to block Na+/K+-ATPases). Increasing the bath concentration of K+ by 5 mM hyperpolarized the membrane potential in both the presence and absence of the endothelium and the responses were similar in arteries from both the SHR and WKY controls. However, in contrast to WKY vessels, K+-induced hyperpolarizations in SHR arteries were virtually abolished by low concentrations of ouabain. From this we conclude that these K+-induced changes were almost totally dependent on Na+/K+-ATPase activation alone, an indication that KIR channels were somehow compromised in SHR vessels. This was indeed confirmed in Western blot experiments that revealed a significant down-regulation in the expression of KIR2.1 protein. This was a remarkable finding; it clearly shows that not only is the KCa2.3 protein reduced in SHR vessels but also that the KIR channel ‘downstream’ of SKCa is also compromised in the hypertensive animals.

A functional loss of KIR in mesenteric arteries from SHR was previously described by Goto et al. (2004). In their experiments, this was associated with a reduction in conducted vasodilatation (a poorly understood phenomenon in which vasodilatation initiated in one part of an artery is able to spread along the vessel; Welsh and Segal, 1998; Takano et al., 2005). However, Goto et al. (2004) found no evidence of a decrease in KIR mRNA and therefore proposed that the functional loss of KIR might be a reflection of the more depolarized myocytes in SHR vessels and the associated reduction in current flow through KIR channels.

In the present study, the myocytes from SHR vessels were also depolarized compared with their WKY controls. It therefore seems reasonable to conclude that the reduced KIR involvement in SHR vessels results not only from the depolarized myocyte membrane potential but also from the observed significant down-regulation in KIR2.1 protein expression.

Are caveolae modified in SHR vessels?

In an earlier study in mesenteric arteries, Absi et al. (2007) showed that SKCa- (but not IKCa-) mediated hyperpolarizations could be selectively inhibited by disruption of caveolae using methyl-β-cyclodextrin (Absi et al., 2007). Furthermore, knockout of caveolin-1, a protein associated with caveolae, reduces EDHF-induced relaxant responses in mouse mesenteric arteries (Saliez et al., 2008). We therefore wondered whether the compromised SKCa–KIR pathway observed in SHR vessels in the present study might also extend to include some failure of the muscarinic M3 receptor to signal specifically to SKCa channels located in endothelial cell caveolae (Absi et al., 2007; Callera et al., 2007; Grgic et al., 2009). In favour of this possibility was the virtual abolition in our SHR vessels of ACh-induced hyperpolarizations mediated by SKCa opening, effects that were arguably too large to result solely from the observed (approximately 50%) reductions in KCa2.3 and KIR2.1 proteins.

In the SHR vessels, there was no change in total caveolin-1 protein. However, the Western blot experiments showed a marked increase in the monomeric form, while caveolin-1 dimers were reduced. On the basis of earlier studies (Callera et al., 2007; see also Grgic et al., 2009) and of the present experiments, we speculate that possible changes within caveolae and/or to associated lipid rafts in SHR vessels affect the ability of activated M3 receptors to induce the opening of SKCa channels. Such effects, when combined with additional reductions in KCa2.3 and KIR2.1 proteins, account for the diminished ACh-mediated hyperpolarizations in SHR vessels and for their almost total dependence on IKCa channel opening.

In conclusion, the present study using mesenteric blood vessels from a rat model of hypertension has shown that there are specific changes in one of the two KCa-dependent dilator pathways associated with ACh-induced, endothelial-dependent hyperpolarization in myocytes. The pathway that involves activation of IKCa and subsequent stimulation of types 2 and 3 Na+/K+-ATPases remains intact. In contrast, both the SKCa and KIR channels that are activated in a parallel signalling sequence are significantly down-regulated in mesenteric arteries from SHR. It is possible that changes in caveolae and/or lipid rafts also compromise the link between M3 receptor activation and SKCa opening. This remarkable compromise of the SKCa–KIR vasodilator pathway is likely to lead to an increase in vascular tone in vivo and thus be a factor that contributes to the elevated arterial blood pressure that is a feature of the SHR.

Acknowledgments

This study was funded by the British Heart Foundation grants FS/07/043 and PG/05/010/18272. We are grateful to Dr H Draheim (Boehringer-Ingelheim, Biberach, Germany) and Dr P Christophersen (Neurosearch A/S, Denmark) for their gifts of CyPPA and NS309 respectively.

Glossary

Abbreviations:

CyPPA

cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine

EDHF

endothelium-derived hyperpolarizing factor

IKCa

native intermediate-conductance, calcium-sensitive K+ channel

KIR

inward-rectifier K+ channel

L-NA

NG-nitro-L-arginine

NS309

6,7-dichloro-1H-indole-2,3-dione 3-oxime

SHR

spontaneously hypertensive rat

SKCa

native small-conductance, calcium-sensitive K+ channel

TRAM-34

1-[(2-chlorophenyl)-diphenyl-methyl]-1H-pyrazole

WKY

Wistar-Kyoto rat

Statement of conflicts of interest

None.

References

  1. Absi M, Burnham MP, Weston AH, Harno E, Rogers M, Edwards G. Effects of methyl beta-cyclodextrin on EDHF responses in pig and rat arteries; association between SKCa channels and caveolin-rich domains. Br J Pharmacol. 2007;151:332–340. doi: 10.1038/sj.bjp.0707222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alexander SPH, Mathie A, Peters JA. Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol. 2009;158(Suppl. 1):S1–S254. doi: 10.1111/j.1476-5381.2009.00499.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alvarez de Sotomayor M, Bueno R, Perez-Guerrero C, Herrera MD. Effect of l-carnitine and propionyl-L-carnitine on endothelial function of small mesenteric arteries from SHR. J Vasc Res. 2007;44:354–364. doi: 10.1159/000102303. [DOI] [PubMed] [Google Scholar]
  4. Burnham MP, Bychkov R, Félétou M, Richards GR, Vanhoutte PM, Weston AH, et al. Characterization of an apamin-sensitive small-conductance Ca2+-activated K+ channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol. 2002;135:1133–1143. doi: 10.1038/sj.bjp.0704551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Callera GE, Montezano AC, Yogi A, Tostes RC, Touyz RM. Vascular signaling through cholesterol-rich domains: implications in hypertension. Curr Opin Nephrol Hyperten. 2007;16:90–104. doi: 10.1097/MNH.0b013e328040bfbd. [DOI] [PubMed] [Google Scholar]
  6. Dal-Ros S, Bronner C, Schott C, Kane MO, Chataigneau M, Schini-Kerth VB, et al. Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery. J Pharmacol Exp Ther. 2009;328:478–486. doi: 10.1124/jpet.108.145326. [DOI] [PubMed] [Google Scholar]
  7. Dora KA, Gallagher NT, McNeish A, Garland CJ. Modulation of endothelial cell KCa3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries. Circ Res. 2008;102:1247–1255. doi: 10.1161/CIRCRESAHA.108.172379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Edwards G, Weston AH. Potassium and potassium clouds in endothelium-dependent hyperpolarizations. Pharmacol Res. 2004;49:535–541. doi: 10.1016/j.phrs.2003.11.013. [DOI] [PubMed] [Google Scholar]
  9. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998;396:269–272. doi: 10.1038/24388. [DOI] [PubMed] [Google Scholar]
  10. Edwards G, Félétou M, Gardener MJ, Thollon C, Vanhoutte PM, Weston AH. Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries. Br J Pharmacol. 1999a;128:1788–1794. doi: 10.1038/sj.bjp.0703009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Edwards G, Gardener MJ, Félétou M, Brady G, Vanhoutte PM, Weston AH. Further investigation of endothelium-derived hyperpolarizing factor (EDHF) in rat hepatic artery: studies using 1-EBIO and ouabain. Br J Pharmacol. 1999b;128:1064–1070. doi: 10.1038/sj.bjp.0702916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Félétou M, Vanhoutte PM. Endothelium-dependent hyperpolarizations: past beliefs and present facts. Ann Med. 2007;39:495–516. doi: 10.1080/07853890701491000. [DOI] [PubMed] [Google Scholar]
  13. Fujii K, Tominaga M, Ohmori S, Kobayashi K, Koga T, Takata Y, et al. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res. 1992;70:660–669. doi: 10.1161/01.res.70.4.660. [DOI] [PubMed] [Google Scholar]
  14. Gardener MJ, Johnson IT, Burnham MP, Edwards G, Heagerty AM, Weston AH. Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol. 2004;142:192–202. doi: 10.1038/sj.bjp.0705691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goto K, Rummery NM, Grayson TH, Hill CE. Attenuation of conducted vasodilatation in rat mesenteric arteries during hypertension: role of inwardly rectifying potassium channels. J Physiol. 2004;561:215–231. doi: 10.1113/jphysiol.2004.070458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Grgic I, Kaistha BP, Hoyer J, Köhler R. Endothelial Ca2+-activated K+ channels in normal and impaired EDHF-dilator responses – relevance to cardiovascular pathologies and drug discovery. Br J Pharmacol. 2009;157:509–526. doi: 10.1111/j.1476-5381.2009.00132.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hammarström AK, Parkington HC, Coleman HA. Release of endothelium-derived hyperpolarizing factor (EDHF) by M3 receptor stimulation in guinea-pig coronary artery. Br J Pharmacol. 1995;115:717–722. doi: 10.1111/j.1476-5381.1995.tb14992.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Harno E, Edwards G, Geraghty AR, Ward DT, Dodd RH, Dauban P, et al. Evidence for the presence of GPRC6A receptors in rat mesenteric arteries. Cell Calcium. 2008;44:210–219. doi: 10.1016/j.ceca.2007.11.011. [DOI] [PubMed] [Google Scholar]
  19. Hilgers RH, Webb RC. Reduced expression of SKCa and IKCa channel proteins in rat small mesenteric arteries during angiotensin II-induced hypertension. Am J Physiol. 2007;292:H2275–H2284. doi: 10.1152/ajpheart.00949.2006. [DOI] [PubMed] [Google Scholar]
  20. Hougaard C, Eriksen BL, Jorgensen S, Johansen TH, Dyhring T, Madsen LS, et al. Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca2+-activated K+ channels. Br J Pharmacol. 2007;151:655–665. doi: 10.1038/sj.bjp.0707281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  22. Saliez J, Bouzin C, Rath G, Ghisdal P, Desjardins F, Rezzani R, et al. Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells. Circulation. 2008;117:1065–1074. doi: 10.1161/CIRCULATIONAHA.107.731679. [DOI] [PubMed] [Google Scholar]
  23. Sandow SL, Neylon CB, Chen MX, Garland CJ. Spatial separation of endothelial small- and intermediate-conductance calcium-activated potassium channels (KCa) and connexins: possible relationship to vasodilator function? J Anat. 2006;209:689–698. doi: 10.1111/j.1469-7580.2006.00647.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Strøbaek D, Teuber L, Jorgensen TD, Ahring PK, Kjaer K, Hansen RS, et al. Activation of human IK and SK Ca2+-activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime) Biochim Biophys Acta. 2004;1665:1–5. doi: 10.1016/j.bbamem.2004.07.006. [DOI] [PubMed] [Google Scholar]
  25. Sunano S, Watanabe H, Tanaka S, Sekiguchi F, Shimamura K. Endothelium-derived relaxing, contracting and hyperpolarizing factors of mesenteric arteries of hypertensive and normotensive rats. Br J Pharmacol. 1999;126:709–716. doi: 10.1038/sj.bjp.0702355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Takano H, Dora KA, Garland CJ. Spreading vasodilatation in resistance arteries. J Smooth Muscle Res. 2005;41:303–311. doi: 10.1540/jsmr.41.303. [DOI] [PubMed] [Google Scholar]
  27. Taylor MS, Bonev AD, Gross TP, Eckman DM, Brayden JE, Bond CT, et al. Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure. Circ Res. 2003;93:124–131. doi: 10.1161/01.RES.0000081980.63146.69. [DOI] [PubMed] [Google Scholar]
  28. Welsh DG, Segal SS. Endothelial and smooth muscle cell conduction in arterioles controlling blood flow. Am J Physiol. 1998;274:H178–H186. doi: 10.1152/ajpheart.1998.274.1.H178. [DOI] [PubMed] [Google Scholar]
  29. Weston AH, Richards GR, Burnham MP, Félétou M, Vanhoutte PM, Edwards G. K+-induced hyperpolarization in rat mesenteric artery: identification, localization and role of Na+/K+-ATPases. Br J Pharmacol. 2002;136:918–926. doi: 10.1038/sj.bjp.0704787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wu CC, Chen SJ, Yen MH. Loss of acetylcholine-induced relaxation by M3-receptor activation in mesenteric arteries of spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1997;30:245–252. doi: 10.1097/00005344-199708000-00015. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES